| Eric P Dudenhofer, ARNP | |
|
820 S Mcclellan St, Suite 426, Spokane, WA 99204-2446 | |
| (509) 456-8444 | |
| (509) 455-9227 |
| Full Name | Eric P Dudenhofer |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 25 Years |
| Location | 820 S Mcclellan St, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114088457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SE0003X | Clinical Nurse Specialist - Emergency | AP30005374 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coulee Medical Center | Grand coulee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas, Grant, Lincoln And Okanogan Counties Public Hospital District | 9335050285 | 24 |
News Archive
Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. This brings with it an increased risk of developing breast cancer.
A report released today by Massachusetts Health Quality Partners provides the first comprehensive assessment of how patients rate their experiences with primary care since the state's groundbreaking health reform law was implemented.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 3 days ago
| Entity Name | Douglas, Grant, Lincoln & Okanogan Counties Public Hospital District 6 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265422935 PECOS PAC ID: 9335050285 Enrollment ID: O20040311000181 |
News Archive
Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. This brings with it an increased risk of developing breast cancer.
A report released today by Massachusetts Health Quality Partners provides the first comprehensive assessment of how patients rate their experiences with primary care since the state's groundbreaking health reform law was implemented.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 3 days ago
| Entity Name | Douglas, Grant, Lincoln & Okanogan Counties Public Hospital District 6 |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1184844185 PECOS PAC ID: 9335050285 Enrollment ID: O20061104000547 |
News Archive
Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. This brings with it an increased risk of developing breast cancer.
A report released today by Massachusetts Health Quality Partners provides the first comprehensive assessment of how patients rate their experiences with primary care since the state's groundbreaking health reform law was implemented.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric P Dudenhofer, ARNP 6831 Hwy 291, Tumtum, WA 99034 Ph: (509) 456-8444 | Eric P Dudenhofer, ARNP 820 S Mcclellan St, Suite 426, Spokane, WA 99204-2446 Ph: (509) 456-8444 |
News Archive
Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. This brings with it an increased risk of developing breast cancer.
A report released today by Massachusetts Health Quality Partners provides the first comprehensive assessment of how patients rate their experiences with primary care since the state's groundbreaking health reform law was implemented.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 3 days ago
Jeffrey Lewis Bailey, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4815 N Assembly St, Spokane, WA 99205 Phone: 509-434-7000 | |
Paula Rachel Sage, RN, BSN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1101 W College Ave, Spokane, WA 99201 Phone: 509-324-1420 | |
Leigh A Harkcom, MN/ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 107 S Division St, Spokane, WA 99202 Phone: 509-838-4651 Fax: 509-363-2762 | |
Debra J Judd, R.N., ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 801 W 5th Ave, Ste 104, Spokane, WA 99204 Phone: 509-747-7066 Fax: 509-838-3148 | |
Ms. Judith Hill Cooke, MA CS ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 707 W 7th Ave, Suite 240, Spokane, WA 99204 Phone: 509-624-8318 Fax: 509-624-0609 | |
Katherine Jones, ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-7500 |